The Induced Pluripotent Stem Cells (iPSCs) Production Market is expected to reach USD 4.2 billion by 2034, rising from USD 1.7 billion in 2024. This growth reflects a CAGR of 9.5% between 2025 and 2034. This upward trend is mainly driven by government support, new biotechnology tools, personalized medicine, and the growing demand for ethical testing models. iPSCs are reprogrammed adult cells...